Clindamycin

Active ingredient description

Clindamycin is a lincosamide antibiotic with a primarily bacteriostatic action against Gram-positive aerobes and a wide range of anaerobic bacteria. Lincosamides such as clindamycin bind to the 50S subunit of the bacterial ribosome and inhibit the early stages of protein synthesis.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code
Group title
Classification
Clindamycin
D Dermatologicals → D10 Anti-acne preparations → D10A Anti-acne preparations for topical use → D10AF Antiinfectives for treatment of acne
Discover more medicines within D10AF01
Clindamycin
G Genito urinary system and sex hormones → G01 Gynecological antiinfectives and antiseptics → G01A ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS → G01AA Antibiotics
Discover more medicines within G01AA10
Clindamycin
J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01F Macrolides, lincosamides and streptogramins → J01FF Lincosamides
Discover more medicines within J01FF01

Medicines

Clindamycin is the active ingredient of these drugs:

Drug
Countries

Hong Kong

Hong Kong

Hong Kong

Hong Kong

Hong Kong

Brazil

Cyprus

Hong Kong

Hong Kong

Hong Kong

Hong Kong

Hong Kong

Hong Kong

Hong Kong

Australia

Hong Kong

Hong Kong

Hong Kong

Hong Kong

United States

United States

United States

United States

Estonia

Hong Kong

Austria

United States

Poland

United States

Germany South Africa

Poland

Australia

Poland

Brazil

Germany

South Africa

Germany

New Zealand

Poland

United States

Hong Kong

Hong Kong

Estonia Spain

Hong Kong

Estonia Finland Ireland Poland South Africa

Estonia Hong Kong Ireland Netherlands Poland

Australia Austria Brazil Canada Cyprus

France Tunisia

Hong Kong

Hong Kong

Hong Kong

Hong Kong

Hong Kong

Hong Kong

Hong Kong

United States

Hong Kong

Cyprus

Hong Kong

Hong Kong

Hong Kong

Hong Kong

Brazil

Hong Kong

Hong Kong

Hong Kong

Hong Kong

Hong Kong

Poland

Poland

Poland

Hong Kong

Hong Kong

Austria

Hong Kong

Hong Kong

Hong Kong

Poland

Hong Kong

Hong Kong

Hong Kong

Hong Kong

Hong Kong

Hong Kong

Hong Kong

Hong Kong

Hong Kong

Estonia Germany

Poland

Hong Kong

Hong Kong

Hong Kong Singapore

Hong Kong Singapore

Hong Kong New Zealand Singapore

Hong Kong

Estonia

Austria Hong Kong Ireland Singapore Spain

France

Clindamycin is also found within below combination drugs:

ACANYA , ACNATAC , ADACNE CLIN , ALESA , BENZACLIN , BENZOLAC-CL , BIACNA , CLIENZO , CLIMADAN , CLINDOXYL , DERIVA C , DUAC , INDOXYL , NEUAC , ONEXTON , TRECLIN , TRECLINAC , VELTIN , VITACID ACNE , ZANEA , ZIANA

Product monographs

Medicine agencies around the world have authorized marketing of this active ingredient according to these medication package inserts (MPIs):

Title
Type
Country
Summary of Product Characteristics (SPC)
UK
Summary of Product Characteristics (SPC)
UK
Summary of Product Characteristics (SPC)
UK
Summary of Product Characteristics (SPC)
UK

Structural formula

Graphic representation of the active ingredient's molecular structure

Unique ingredient identifier (UNII)

3U02EL437C - CLINDAMYCIN

CAS registry number

18323-44-9 - clindamycin

21462-39-5 - Clindamycin hydrochloride

24729-96-2 - Clindamycin phosphate

SNOMED-CT

372786004 - Clindamycin (substance)